Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine

Journal of Infectious Diseases

Volumn 159, Issue 4, 1989, Pages 610-615

  Ljungman, P ^b   Lonnqvist, B ^a   Bolme, P ^a   Bottiger, M ^a   Gahrton, G ^a   Linde, A ^a   Ringden, O ^a   Wahren, B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MEASLES VACCINE; METHOTREXATE; MUMPS VACCINE; RUBELLA VACCINE; VACCINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; MUMPS; MUMPS VACCINE; MUMPS VIRUS; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; VACCINES, ATTENUATED;

EID: 0024580367     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/159.4.610     Document Type: Article

References (25)

1. Wahren B, Gahrton G, Linde A, Ljungman P. Lonnqvist B, Ringden O, Sundqvist VA.Transfer and persistence of viral anitbody-producing cells in bone marrow transplantation. J Infect Dis 1984;150:358-65
2. Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J 1987;295:1264-7
3. Mitus A, Holloway A, Evans AE, et al. Attenuated measles vaccine in children with leukemia. Am J Dis Child 1962;103:243-8
4. Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. JAMA 1973;223:1459-62
5. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975;292:832-43, 895-902
6. Ringden O, Lonnqvist B, Lundgren G, Gahrton G, Groth CG, Moller E, Baryd I, Johansson B, Pihlstedt P, Gullbring B. Experience with a cooperative bone marrow transplantation program in Stockholm. Transplantation 1982;33: 500-4
7. Ringden O, Backman L, Uinnqvist B, Heimdahl A, Lindholm A, Bolme P, Gahrton G. A randomized trial comparing use of cyclosporinand methotrexate for graft-versushost disease prophylaxis in bone marrow transplant recipients with haematologic malignancy. Bone Marrow Transplant 1986;1:41-9
8. Storb R, Deeg HJ, Whitehead J, et al. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of graft-versus-host disease. Transplant Proc 1987;19: 2608-13
9. Storb R, Deeg HJ, Whitehead J, et al. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of graft-versus-host disease. Transplant Proc 1987;19: 2608-13
10. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED. Chronic graft-versus-host disease in man, a long time clinico-pathologic study of 20 Seattle patients. Am J Moo 1980;169:204-17
11. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, Truelove EL, Sale GE, Buckner CD, Storb R, Thomas ED. Oral manifestations of chronic graftversus- host disease. Arch Intern Med 1984;144:1591-5
12. Linde GA, Granstrom M, Orvell C. Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity. J Clin Microbiol 1987;25:1653-8
13. Orvell C. Structural polypeptides of mumps virus. J Gen Virol 1978;41:527-39
14. Breitfeld V, Hashida Y, Sherman FE, et al. Fatal measles infection in children with leukemia. Lab Invest 1973;29: 279-91
15. Aicardi J, Goutieres F, Arseni-Nunes ML, et al. Acute measlesencephalitis in children with immunosuppression. Pediatrics 1977;59:232-9
16. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, Noel D, Thomas ED. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720-31
17. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80
18. Krugman S, Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr 1977;90:1-12
19. Rabo E, Taranger J. Scandinavian model for eliminating measles, mumps and rubella. Br Med J 1984;289:1402-4
20. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine:a double-blind placebocontrolled trial in twins. Lancet 1986;1:939-41
21. Chandler JK, Ford DK, Tingle AJ. Rubella-associated arthri tis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination. Infect Immun 1981;32: 1274-80
22. Recommendation of the Immunization Practices Advisory Committee: measles prevention. MMWR 1987;36:409-25
23. Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson K, Thomas ED. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981;58:360-7 615
24. Lum LG, Seigneuret MC, Storb R, Witherspoon RP, Thomas ED. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft -versus-host disease. Blood 1981;58:431-9
25. Paulin T, Ringden O, Nilsson B. Immunological recovery after bone marrow transplantation: role of age, graft –versushost disease, prednisolone treatment and infections. Bone Marrow Transplant 1987;1:317-28